ROCKVILLE, Md., March 21, 2014 /PRNewswire/ -- EntreMed, Inc. (ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, today reported financial results for the three and 12 months ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
